Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL29038646 | 0.95 | KMT2A (0.51) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL21438669 | 0.92 | MEN1 (0.50) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL10795218 | 0.87 | CYP1A2 (0.43) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL25334951 | 0.86 | KMT2A (0.55) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL7698304 | 0.85 | MEN1 (0.43) | MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL11440835 | 0.85 | CYP1A2 (0.52) | MEN1KMT2ACYP1A2ERBB2FYN | |
| SCHEMBL27633062 | 0.84 | MEN1 (0.41) | MEN1KMT2A | |
| SCHEMBL29041190 | 0.84 | MEN1 (0.47) | MEN1KMT2AALDH1A1KDM4EHPGD | |
| SCHEMBL27653491 | 0.84 | MEN1 (0.41) | MEN1KMT2A | |
| SCHEMBL3930862 | 0.84 | ALDH1A1 (0.48) | MEN1KMT2ACYP1A2ERBB2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9758646-B2 | NdBR wet masterbatch | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-09-12 | — | — | US | claimed |
| CN-105001467-A | NdBR wet masterbatch and preparing method and use thereof | LANXESS DEUTSCHLAND GMBH | 2015-10-28 | — | — | CN | claimed |
| US-20140309332-A1 | NDBR WET MASTERBATCH | ARLANXEO DEUTSCHLAND GMBH (DE) | 2014-10-16 | — | — | US | claimed |
| EP-2773692-A1 | NDBR WET MASTERBATCH | LANXESS Deutschland GmbH (DE) | 2014-09-10 | — | — | EP | claimed |
| CN-103958575-A | NDBR wet masterbatch | LANXESS DEUTSCHLAND GMBH | 2014-07-30 | — | — | CN | claimed |
| WO-2013064434-A1 | NDBR WET MASTERBATCH | LANXESS DEUTSCHLAND GMBH (DE) | 2013-05-10 | — | — | WO | claimed |
| WO-2013066329-A1 | NdBR WET MASTERBATCH | LANXESS DEUTSCHLAND GMBH (DE) | 2013-05-10 | — | — | WO | claimed |
| CN-1955164-A | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds | ABBOTT LAB (US) | 2007-05-02 | — | — | CN | claimed |
| CN-1113434-A | Drug | DROSSAPHARM AG (CH) | 1995-12-20 | — | — | CN | claimed |
| WO-2023230531-A1 | METHODS FOR DETECTING CIRCULATING GENETICALLY ABNORMAL CELLS | LUNGLIFE AI, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230266325-A1 | METHODS FOR DETECTING LUNG CANCER | LUNGLIFE AI, INC. | 2023-08-24 | — | — | US | disclosed |
| CN-116477731-A | Flocculant for removing COD in coal gasification phenol-containing wastewater and preparation method thereof | 内蒙古南大环保科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| CN-116161809-A | Separation method of coking desulfurization waste liquid | 常州德帝士环保科技有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-20060078885-A1 | Detection and diagnosis of smoking related cancers | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-04-13 | — | — | US | disclosed |
| US-6797471-B2 | SCREENING FOR TUMORS IN HUMANS; OBTAIN SAMPLE, INCUBATE WITH PROBES, MONITORING ABBERATIONS IN HYDRIDIZATION PATTERN COMPAREDE TO CONTROL | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-09-28 | — | — | US | disclosed |
| US-20020081612-A1 | Detection and diagnosis of smoking related cancers | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-06-27 | — | — | US | disclosed |
| WO-2002012563-A2 | DETECTION AND DIAGNOSIS OF SMOKING RELATED CANCERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2002-02-14 | — | — | WO | disclosed |
| CN-1113434-A | Drug | DROSSAPHARM AG (CH) | 1995-12-20 | — | — | CN | disclosed |
| US-4636212-A | COPOLYMER OF METHYL METHACRYLATE AND BENZOPHENONE DERIVATIVE IN MATRIX OF POLYMETHYL METHACRYLATE | OPTICAL RADIATION CORPORATION (US) | 1987-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | MEN1 853/4885KMT2A 801/4885CYP1A2 303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.